what are the Recommendations for AF Complicating ACS?
If triple therapy (oral anticoagulant, aspirin, and P2Y inhibitor) is prescribed for patients 12 with AF who are at increased risk of stroke (based on CHADS-VASc risk score of 2 or 2 2 greater) and who have undergone PCI with stenting (drug eluting or bare metal) for ACS, a transition to double therapy (oral anticoagulant and P2Y inhibitor) at 4 to 6 12 weeks may be considered.S7.4-9,S7.4-10 NEW: New published data are available.